EARLY CONFIRMED TOP INDUSTRY Speakers

 

Kate Adcock, Director of Research and Innovation, The Muscular Dystrophy U.K.

Kate Adcock | Director of Research and Innovation | The Muscular Dystrophy U.K. » speaking at PPMA 2020

Jeonghoon Ahn, Director, National Evidence-based Healthcare Collaborating Agency

Jeonghoon Ahn | Director | National Evidence-based Healthcare Collaborating Agency » speaking at PPMA 2020

Tanya Aiden, Global Products Lead, BIOCAD

Tanya Aiden | Global Products Lead | BIOCAD » speaking at PPMA 2020

John Alter, Vice President Pricing And Market Access, Pfizer

John Alter | Vice President Pricing And Market Access | Pfizer » speaking at PPMA 2020

Mauricio Alvarez Reyes, Market Access Expert, Independent

Mauricio Alvarez Reyes | Market Access Expert | Independent » speaking at PPMA 2020

Sofie Alverlind, Project Manager, Swedish Association of Local Authorities and Regions

Ines Alves, President, ANDO Portugal

Ines Alves | President | ANDO Portugal » speaking at PPMA 2020

Diego Ardigo, R&D Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Diego Ardigo | R&D Rare Diseases Unit Head | Chiesi Farmaceutici SpA » speaking at PPMA 2020

Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, National Institute for Health and Disability Insurance RIZIV-INAMI

Francis Arickx | Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy | National Institute for Health and Disability Insurance RIZIV-INAMI » speaking at PPMA 2020

Ramesh Arjunji, Senior Director Heor And Rwe, AveXis

Ramesh Arjunji | Senior Director Heor And Rwe | AveXis » speaking at PPMA 2020

Nadeem Ashraf, Medical Advisor - Diabetes, N/A

Kagan Atikeler, Pharmacist, Turkish Medicines and Medical Devices Agency

Kagan Atikeler | Pharmacist | Turkish Medicines and Medical Devices Agency » speaking at PPMA 2020

Antje Behring, Acting Head, Federal Joint Committee

Antje Behring | Acting Head | Federal Joint Committee » speaking at PPMA 2020

Inge Bliestle, Chief Operating Officer, TolerogenixX

Inge Bliestle | Chief Operating Officer | TolerogenixX » speaking at PPMA 2020

Nadia Bodkin, Rare Disease Advocacy Professional, Rare Advocacy Movement

Nadia Bodkin | Rare Disease Advocacy Professional | Rare Advocacy Movement » speaking at PPMA 2020

Axel Boehnke, Director Market Access EU North, PTC Therapeutics

Axel Boehnke | Director Market Access EU North | PTC Therapeutics » speaking at PPMA 2020

Luc Boileau, Chairman and Chief Executive Officer, Inesss

Luc Boileau | Chairman and Chief Executive Officer | Inesss » speaking at PPMA 2020

Hassan Bruneo, Associate Director, Alnylam Switzerland Gmbh

Hassan Bruneo | Associate Director | Alnylam Switzerland Gmbh » speaking at PPMA 2020

Anna Bucsics, Project Advisor, MoCA - Mechanism of Coordinated Access to Orphan M

Anna Bucsics | Project Advisor | MoCA - Mechanism of Coordinated Access to Orphan M » speaking at PPMA 2020

Rob Burley, Director of Campaigns, Care & Support, The Muscular Dystrophy U.K.

Rob Burley | Director of Campaigns, Care & Support | The Muscular Dystrophy U.K. » speaking at PPMA 2020

Nicki Catterick, Senior Director, Global Market Access and Pricing, Merck Group

Nicki Catterick | Senior Director, Global Market Access and Pricing | Merck Group » speaking at PPMA 2020

David Catterick, Health Economics Senior Manager, Amgen

David Catterick | Health Economics Senior Manager | Amgen » speaking at PPMA 2020

Sandro Cesaro-Tadic, Head Pricing I8 & Product Pricing Strategies, Roche

Sandro Cesaro-Tadic | Head Pricing I8 & Product Pricing Strategies | Roche » speaking at PPMA 2020

Anjan Chatterjee, Global Head Of Real World Evidence, Boehringer Ingelheim Pharma GmbH & Co. KG

Anjan Chatterjee | Global Head Of Real World Evidence | Boehringer Ingelheim Pharma GmbH & Co. KG » speaking at PPMA 2020

Americo Cicchetti, Director, Universita Cattolica Del Sacro Cuore

Americo Cicchetti | Director | Universita Cattolica Del Sacro Cuore » speaking at PPMA 2020

Ali Ciger, Commercial Director, Pain, Pfizer

Ali Ciger | Commercial Director, Pain | Pfizer » speaking at PPMA 2020

Francis Crawley, Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer), Good Clinical Practice Alliance (GCPA)

Francis Crawley | Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer) | Good Clinical Practice Alliance (GCPA) » speaking at PPMA 2020

Omar Dabbous, VP, Health Economics And Outcomes Research, AveXis

Omar Dabbous | VP, Health Economics And Outcomes Research | AveXis » speaking at PPMA 2020

Charles De Cidrac, Director Of Health Insurance, AXA

Charles De Cidrac | Director Of Health Insurance | AXA » speaking at PPMA 2020

Carla Deakin, Programme Director - Commercial And Managed Access, NICE

Carla Deakin | Programme Director - Commercial And Managed Access | NICE » speaking at PPMA 2020

Olga Diachenko, Market Access Manager Europe, Accord Healthcare

Olga Diachenko | Market Access Manager Europe | Accord Healthcare » speaking at PPMA 2020

Valentin Dodonov, Deputy General Head Of Market Access, BIOCAD

Valentin Dodonov | Deputy General Head Of Market Access | BIOCAD » speaking at PPMA 2020

Mark Duman, Nw Service Champion, Diabetes U.K.

Mark Duman | Nw Service Champion | Diabetes U.K. » speaking at PPMA 2020

Rudy Dupree, Senior Project Manager, Eunethta Wp4, EUnetHTA

Rudy Dupree | Senior Project Manager, Eunethta Wp4 | EUnetHTA » speaking at PPMA 2020

Jenny Ebert, National Account Director, Genzyme Sanofi Corp

Jenny Ebert | National Account Director | Genzyme Sanofi Corp » speaking at PPMA 2020

Gottfried Endel, EBM, HTA Team Leader, H.V.B.

Gottfried Endel | EBM, HTA Team Leader | H.V.B. » speaking at PPMA 2020

Michael Ermisch, Specialist, Department Of Pharmaceuticals, G.K.V. Spitzenverband

Michael Ermisch | Specialist, Department Of Pharmaceuticals | G.K.V. Spitzenverband » speaking at PPMA 2020

Valerie Faillat, Head Of Sanofi Espoir Foundation, SANOFI

Valerie Faillat | Head Of Sanofi Espoir Foundation | SANOFI » speaking at PPMA 2020

Rute Fernandes, Head of Rare Diseases of Europe and Canada, Takeda

Rute Fernandes | Head of Rare Diseases of Europe and Canada | Takeda » speaking at PPMA 2020

Girisha Fernando, CEO, Lyfegen HealthTech AG

Girisha Fernando | CEO | Lyfegen HealthTech AG » speaking at PPMA 2020

Martina Flammer, Senior Vice President, Head Of Corporate Customer Value, Boehringer-Ingelheim

Oliver Gassner, Head Digital Health Intelligence | Emea, Bayer

Oliver Gassner | Head Digital Health Intelligence | Emea | Bayer » speaking at PPMA 2020

Katrien Van Geyt, Head of Market Access, Belgium & Luxembourg, Takeda

Katrien Van Geyt | Head of Market Access, Belgium & Luxembourg | Takeda » speaking at PPMA 2020

Fabrizio Gianfrate, Professor of Health Economics, Mkt Access Advisor, Universities of Rome and Ferrara

Fabrizio Gianfrate | Professor of Health Economics, Mkt Access Advisor | Universities of Rome and Ferrara » speaking at PPMA 2020

Josie Godfrey, Director, JG Zebra Consulting

Josie Godfrey | Director | JG Zebra Consulting » speaking at PPMA 2020

Wim Goettsch, Special HTA-advisor, Zorginstituut

Wim Goettsch | Special HTA-advisor | Zorginstituut » speaking at PPMA 2020

Clare Hague, Therapy Area Market Access Lead, Hematology, Janssen Pharmaceutical

Clare Hague | Therapy Area Market Access Lead, Hematology | Janssen Pharmaceutical » speaking at PPMA 2020

Stephen Hall, Knowledge Exchange Associate, NIHR Innovation Observatory, Newcastle University

Stephen Hall | Knowledge Exchange Associate | NIHR Innovation Observatory, Newcastle University » speaking at PPMA 2020

Adam Heathfield, Senior Director of Global Health And Value Innovation Centre, Pfizer Ltd

Adam Heathfield | Senior Director of Global Health And Value Innovation Centre | Pfizer Ltd » speaking at PPMA 2020

Stefan Holmstrom, Head, HTA Strategy and PRO excellence, Astellas Pharma

Stefan Holmstrom | Head, HTA Strategy and PRO excellence | Astellas Pharma » speaking at PPMA 2020

Birgit Holz, Global Head Of Contracting Innovation, Sanofi

Birgit Holz | Global Head Of Contracting Innovation | Sanofi » speaking at PPMA 2020

Patrick Hopkinson, Executive Director, Wwheor Markets, Bristol-Myers Squibb

Nigel Hughes, Scientific Director, RMEDS Quantitative Sciences,, Janssen

Wills Hughes-Wilson, Head Of Patient Access And Commercial Planning, Mereo BioPharma

Kankendria Ingram, Independent, Independent

Kankendria Ingram | Independent | Independent » speaking at PPMA 2020

Dawn Torrence Ireland, President And Founder, C.H.E.R.U.B.S.

Dawn Torrence Ireland | President And Founder | C.H.E.R.U.B.S. » speaking at PPMA 2020

Ulrike Jacobi, Head Of External Affairs And Market Access, Amgen

Ulrike Jacobi | Head Of External Affairs And Market Access | Amgen » speaking at PPMA 2020

David Jakouloff, Global Head Of Market Access, Dmd, PTC Therapeutics

David Jakouloff | Global Head Of Market Access, Dmd | PTC Therapeutics » speaking at PPMA 2020

Rasmus Jensen, Global Head Of Market Access, Camurus

Rasmus Jensen | Global Head Of Market Access | Camurus » speaking at PPMA 2020

Wendy Jory, Head Of Global Pricing Centre Of Excellence, GlaxoSmithKline

Wendy Jory | Head Of Global Pricing Centre Of Excellence | GlaxoSmithKline » speaking at PPMA 2020

Navin Joshi, Global Head of Pricing, Classic & Established Products. Global Pharma, Head of Pricing & Access Capabilities, Emerging Markets, GlaxoSmithKline

Navin Joshi | Global Head of Pricing, Classic & Established Products. Global Pharma, Head of Pricing & Access Capabilities, Emerging Markets | GlaxoSmithKline » speaking at PPMA 2020

Marcela Junqueira, Head Of Strategic Affairs And Health Economics, The Janssen Pharmaceutical

Marcela Junqueira | Head Of Strategic Affairs And Health Economics | The Janssen Pharmaceutical » speaking at PPMA 2020

Lisette Kaskens, Global Head Of Pricing And Market Access, Ferrer

Lisette Kaskens | Global Head Of Pricing And Market Access | Ferrer » speaking at PPMA 2020

Jolanda Koenders, Head Of Pricing And Market Access Pharma, Novartis

Jolanda Koenders | Head Of Pricing And Market Access Pharma | Novartis » speaking at PPMA 2020

Shanthy Krishnaraja, Sr. Director, Market Access and Strategy, Seqirus

Shanthy Krishnaraja | Sr. Director, Market Access and Strategy | Seqirus » speaking at PPMA 2020

Adam Kundzewicz, Senior Global Payer Strategy Manager, Head Of Pricing, Boehringer Ingelheim Pharma GmbH & Co. KG

Marie-Liesse Le Corfec, Global Portfolio Marketing Head, Ps, B.D. Pharmaceuticals Systems

Marie-Liesse Le Corfec | Global Portfolio Marketing Head, Ps | B.D. Pharmaceuticals Systems » speaking at PPMA 2020

Jost Leemhuis, Head of Safety Science, Roche

Jost Leemhuis | Head of Safety Science | Roche » speaking at PPMA 2020

Sandy Leonard, Vice President Of Medical Evidence And Observational Research, AstraZeneca

Sandy Leonard | Vice President Of Medical Evidence And Observational Research | AstraZeneca » speaking at PPMA 2020

Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer

Friedhelm Leverkus | Director Health Technology Assessment And Outcomes Research | Pfizer » speaking at PPMA 2020

Gavin Lewis, Vice President Of Value, Access And Policy, Amgen

Gavin Lewis | Vice President Of Value, Access And Policy | Amgen » speaking at PPMA 2020

Sune Lindgaard, Chief Of Business Intelligence, Amgros, Denmark

Sune Lindgaard | Chief Of Business Intelligence | Amgros, Denmark » speaking at PPMA 2020

Catarina Lopes Pereira, Market Access Manager, Medicines for Europe

Catarina Lopes Pereira | Market Access Manager | Medicines for Europe » speaking at PPMA 2020

Mark Macgregor, Co-Vice Chair, Scottish Medicines Consortium, Nhs Scotland

Mark Macgregor | Co-Vice Chair, Scottish Medicines Consortium | Nhs Scotland » speaking at PPMA 2020

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Steinar Madsen | Medical Director | Norwegian Medicines Agency, Norway » speaking at PPMA 2020

Joerg Mahlich, Head of Health, Janssen Pharmaceutical K.K.

Andrea Mantovani, Former Head of Value, Access & Policy for Biopharma Companies, Independent

Andrea Mantovani | Former Head of Value, Access & Policy for Biopharma Companies | Independent » speaking at PPMA 2020

Marco Marchetti, Director Of The National Center For Health Technology Assessment, Istituto Superiore di Sanita

Marco Marchetti | Director Of The National Center For Health Technology Assessment | Istituto Superiore di Sanita » speaking at PPMA 2020

Anne Marciniak, Head Of Market Access, Europe, Aimmune

Anne Marciniak | Head Of Market Access, Europe | Aimmune » speaking at PPMA 2020

Cristina Martin-Rinconada, Head Of Value And Access For International Partners Markets (Mena And Ceer Regions), Biogen

Cristina Martin-Rinconada | Head Of Value And Access For International Partners Markets (Mena And Ceer Regions) | Biogen » speaking at PPMA 2020

Kevin Mayo, Global Head Of Market Access And New Products, PTC Therapeutics

Kevin Mayo | Global Head Of Market Access And New Products | PTC Therapeutics » speaking at PPMA 2020

Vipul Modi, Head of Transformation for Innovation, Digital and Life Sciences, Oxford Academic Health Science Network

Vipul Modi | Head of Transformation for Innovation, Digital and Life Sciences | Oxford Academic Health Science Network » speaking at PPMA 2020

Patrick Mollon, HEOR Consultant, GMAP, Ipsen Pharma

Patrick Mollon | HEOR Consultant, GMAP | Ipsen Pharma » speaking at PPMA 2020

Tal Morginstin, Director, Nlhs (National List Of Health Services) Assessment Division, Ministry of Health

Tal Morginstin | Director, Nlhs (National List Of Health Services) Assessment Division | Ministry of Health » speaking at PPMA 2020

Thomas Mueller, Head Of Directorate General 1 "Drugs, Medical Devices, Biotechnology", Federal Ministry of Health Germany

Thomas Mueller | Head Of Directorate General 1 'Drugs, Medical Devices, Biotechnology' | Federal Ministry of Health Germany » speaking at PPMA 2020

Michael Müller, Head of Market Access, Western Europe, Sun Pharma

Michael Müller | Head of Market Access, Western Europe | Sun Pharma » speaking at PPMA 2020

Peter Mulley, Director Global Market Access, ViiV Healthcare

Peter Mulley | Director Global Market Access | ViiV Healthcare » speaking at PPMA 2020

Diane Munch, Head Of Global Pricing, Patient And Health Impact, Pfizer

Diane Munch | Head Of Global Pricing, Patient And Health Impact | Pfizer » speaking at PPMA 2020

Nuriya Musina, Head of Development, Federal State Budgetary Institution, the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the R

Nuriya Musina | Head of Development | Federal State Budgetary Institution, the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the R » speaking at PPMA 2020

Hanadi Nahas, Chairman And General Manager, Access Core

Hanadi Nahas | Chairman And General Manager | Access Core » speaking at PPMA 2020

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Alexander Natz | Secretary General | European Confederation of Pharmaceutical Entrepreneurs (Belgium) » speaking at PPMA 2020

Enkeleida Nikai, Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea), Janssen Pharmaceutical

Enkeleida Nikai | Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea) | Janssen Pharmaceutical » speaking at PPMA 2020

Waldemar Ockert, Director, Rwi Business Market Analytics, Astellas Pharma

Waldemar Ockert | Director, Rwi Business Market Analytics | Astellas Pharma » speaking at PPMA 2020

Irina Odnoletkova, Vice President Health Technology Assessment, Apogenix Gmbh

Irina Odnoletkova | Vice President Health Technology Assessment | Apogenix Gmbh » speaking at PPMA 2020

Laura O'Hanlon, Associate Director, International Market Access/Reimbursement, Myriad genetics

Laura O'Hanlon | Associate Director, International Market Access/Reimbursement | Myriad genetics » speaking at PPMA 2020

Melvin Olson, Global Head Rwd Strategy And Innovation, Novartis Pharma

Melvin Olson | Global Head Rwd Strategy And Innovation | Novartis Pharma » speaking at PPMA 2020

Robert Orzechowski, Chief Operating Officer, Lancaster Cancer Centre

Robert Orzechowski | Chief Operating Officer | Lancaster Cancer Centre » speaking at PPMA 2020

Arrigo Paciello, Scientific Advisor, AIFA

Arrigo Paciello | Scientific Advisor | AIFA » speaking at PPMA 2020

Melissa Paige, Uva Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate, U.V.A. Health System

Melissa Paige | Uva Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate | U.V.A. Health System » speaking at PPMA 2020

Ana Palma, Senior Director Global Hta And Patient Access Lead, Sobi

Ana Palma | Senior Director Global Hta And Patient Access Lead | Sobi » speaking at PPMA 2020

Elena Panitti, Global Rwe Capability Building Lead, Novartis

Elena Panitti | Global Rwe Capability Building Lead | Novartis » speaking at PPMA 2020

Detlev Parow, Head Pharmaceutical Department, D.A.K.

Detlev Parow | Head Pharmaceutical Department | D.A.K. » speaking at PPMA 2020

Chris Pashos, Vice President Of Global Evidence Strategy, AbbVie

Chris Pashos | Vice President Of Global Evidence Strategy | AbbVie » speaking at PPMA 2020

Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim

Marco Penske | Head Of Market Access And Health Care Affairs | Boehringer-Ingelheim » speaking at PPMA 2020

Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.

Andres Pichon Riviere | Executive Director And Director Of Health Technology Assessment And Economic Evaluations | I.E.C.S. » speaking at PPMA 2020

Lara Pippo, Head Of Market Access, CSL Behring

Lara Pippo | Head Of Market Access | CSL Behring » speaking at PPMA 2020

Sarah Pitluck, Head, Global Pricing And Reimbursement, Spark Therapeutics

Sarah Pitluck | Head, Global Pricing And Reimbursement | Spark Therapeutics » speaking at PPMA 2020

Robert Popovian, Vice President Of Government Relations, Pfizer

Robert Popovian | Vice President Of Government Relations | Pfizer » speaking at PPMA 2020

Diann Potestio, Vice President Market Access, Ascendis Pharma

Diann Potestio | Vice President Market Access | Ascendis Pharma » speaking at PPMA 2020

Martin Price, Vice President Of Health Economics, Market Access And Reimbursement, Johnson & Johnson

Martin Price | Vice President Of Health Economics, Market Access And Reimbursement | Johnson & Johnson » speaking at PPMA 2020

Andrew Richards, Head Of Global Market Access And Pricing, Ferring

Andrew Richards | Head Of Global Market Access And Pricing | Ferring » speaking at PPMA 2020

Kevin Rieger, Head Of Eu Affairs, BPI

Kevin Rieger | Head Of Eu Affairs | BPI » speaking at PPMA 2020

Juan Roman, Head of Market Access & Pricing, Acceleron Pharmaceuticals, Inc.

Juan Roman | Head of Market Access & Pricing | Acceleron Pharmaceuticals, Inc. » speaking at PPMA 2020

Giuseppe Rosano, Member Of The Cardiovascular Working Party, European Medicines Agency

Giuseppe Rosano | Member Of The Cardiovascular Working Party | European Medicines Agency » speaking at PPMA 2020

Micah Rose, Senior Scientific Adviser, Health Economic Modelling, National Institute for Health and Care Excellence

Micah Rose | Senior Scientific Adviser, Health Economic Modelling | National Institute for Health and Care Excellence » speaking at PPMA 2020

Igor Rudychev, Head of US Digital, Data, and Innovations, AstraZeneca

Igor Rudychev | Head of US Digital, Data, and Innovations | AstraZeneca » speaking at PPMA 2020

Peter Rutherford, Global Medical Lead Of Orphan Renal Diseases, Vifor Pharma Group

Peter Rutherford | Global Medical Lead Of Orphan Renal Diseases | Vifor Pharma Group » speaking at PPMA 2020

Ryan Saadi, Vice President, Global Market Access, CSL Behring

Ryan Saadi | Vice President, Global Market Access | CSL Behring » speaking at PPMA 2020

Rasha Salama, Ministry Public Health Consultant and Advisor, Ministry Of Health

Rasha Salama | Ministry Public Health Consultant and Advisor | Ministry Of Health » speaking at PPMA 2020

Steve Sandor, Vice President, Market Access And Trade, Paratek Pharmaceuticals , Inc.

Steve Sandor | Vice President, Market Access And Trade | Paratek Pharmaceuticals , Inc. » speaking at PPMA 2020

Gustavo Saraiva Dos Anjos, Global Market Access Director for Biologics, GlaxoSmithKline

Gustavo Saraiva Dos Anjos | Global Market Access Director for Biologics | GlaxoSmithKline » speaking at PPMA 2020

Gundula Schneidewind, Head Ethics And Compliance, Europe And Canada, Takeda

Gundula Schneidewind | Head Ethics And Compliance, Europe And Canada | Takeda » speaking at PPMA 2020

Michael Schroter, Partner, Viopas Partners

Michael Schroter | Partner | Viopas Partners » speaking at PPMA 2020

Ad Schuurman, Senior Advisor International Affairs, National Health Care Institute (ZIN), the Netherlands

Ad Schuurman | Senior Advisor International Affairs | National Health Care Institute (ZIN), the Netherlands » speaking at PPMA 2020

Nabil Seidov, Deputy Head of Department for Health Policy and Planning of Public Health and Reforms Centre, Ministry of Healthcare of Azerbaijan Republic

Nabil Seidov | Deputy Head of Department for Health Policy and Planning of Public Health and Reforms Centre | Ministry of Healthcare of Azerbaijan Republic » speaking at PPMA 2020

Ayman Semaan, Head Of Market Access, Algorithm

Ayman Semaan | Head Of Market Access | Algorithm » speaking at PPMA 2020

Simon Shohet, Senior Director, Global Market Access And Pricing, Ipsen

Simon Shohet | Senior Director, Global Market Access And Pricing | Ipsen » speaking at PPMA 2020

Rita Shorjian, Market Access Head - Near East & North West Africa, AbbVie

Rita Shorjian | Market Access Head - Near East & North West Africa | AbbVie » speaking at PPMA 2020

Dorinda Silva, Volunteer Patient Advocate, Portuguese Association for CDG and other Rare Metabolic Diseases

Dorinda Silva | Volunteer Patient Advocate | Portuguese Association for CDG and other Rare Metabolic Diseases » speaking at PPMA 2020

Tamir Singer, Head Of Commercial Development, Specialised Commissioning, NHS England

Tamir Singer | Head Of Commercial Development, Specialised Commissioning | NHS England » speaking at PPMA 2020

Ulf Staginnus, Senior Vice President, Head Of Global Market Access And Pricing, Ipsen Pharma

Ulf Staginnus | Senior Vice President, Head Of Global Market Access And Pricing | Ipsen Pharma » speaking at PPMA 2020

Anastasiya Stepanova, State Authorities Manager, JSC Nizhpharm

Anastasiya Stepanova | State Authorities Manager | JSC Nizhpharm » speaking at PPMA 2020

Richard Stephens, Patient Advocate, National Cancer Research Institute (NCRI)

Richard Stephens | Patient Advocate | National Cancer Research Institute (NCRI) » speaking at PPMA 2020

Giovanni Tafuri, EUnetHTA, Senior Scientific Officer, National Health Care Institute (ZIN), the Netherlands

Giovanni Tafuri | EUnetHTA, Senior Scientific Officer | National Health Care Institute (ZIN), the Netherlands » speaking at PPMA 2020

Bertrand Tardivel, General Manager, Frehel GmbH

Bertrand Tardivel | General Manager | Frehel GmbH » speaking at PPMA 2020

Samuel Taylor, Emerging Markets Pricing Lead, Pfizer

Samuel Taylor | Emerging Markets Pricing Lead | Pfizer » speaking at PPMA 2020

Renske Ten Ham, Researcher, Utrecht University

Renske Ten Ham | Researcher | Utrecht University » speaking at PPMA 2020

Gwilym Thompson, Director Worldwide Heor, BMS

Gwilym Thompson | Director Worldwide Heor | BMS » speaking at PPMA 2020

Daria Tolkacheva, Head Of Health Economics, JSC BIOCAD

Daria Tolkacheva | Head Of Health Economics | JSC BIOCAD » speaking at PPMA 2020

Jorg Tomeczkowski, Head Of Market Access, Janssen Cilag Germany

Jorg Tomeczkowski | Head Of Market Access | Janssen Cilag Germany » speaking at PPMA 2020

Keiko Tone, Vice President Global Market Access, Shionogi Inc

Keiko Tone | Vice President Global Market Access | Shionogi Inc » speaking at PPMA 2020

Ariella Toren, Director Of Medicine And Medical Technologies, Hmos Department, Israel - Ministry Of Health

Ariella Toren | Director Of Medicine And Medical Technologies, Hmos Department | Israel - Ministry Of Health » speaking at PPMA 2020

Maarten Van Baelen, Market Access Director, Medicines

Maarten Van Baelen | Market Access Director | Medicines » speaking at PPMA 2020

Bart Van Den Daele, Head of External Affairs – Director Market Access, Gilead Sciences

Bart Van Den Daele | Head of External Affairs – Director Market Access | Gilead Sciences » speaking at PPMA 2020

Goedele Van Haasteren, Hta Specialist, Swiss Federal Office of Public Health

Evert Jan Van Lente, Director of EU Affairs, AOK Bundesverdand

Evert Jan Van Lente | Director of EU Affairs | AOK Bundesverdand » speaking at PPMA 2020

Christina Vandoros, Director, Macroeconomics & Health Policy - Emea, Janssen

Christina Vandoros | Director, Macroeconomics & Health Policy - Emea | Janssen » speaking at PPMA 2020

Stefan Vegter, Market Access Manager, Novartis

Stefan Vegter | Market Access Manager | Novartis » speaking at PPMA 2020

Entela Xoxi, Former Aifa, Universita Cattolica Del Sacro Cuore

Entela Xoxi | Former Aifa | Universita Cattolica Del Sacro Cuore » speaking at PPMA 2020

Natasa Zibelnik, Global Head of Market Access, E.U.S.A. Pharma

Natasa Zibelnik | Global Head of Market Access | E.U.S.A. Pharma » speaking at PPMA 2020

Martine Zimmermann, Global Head Of Regulatory Affairs, Alexion Pharmaceuticals

Martine Zimmermann | Global Head Of Regulatory Affairs | Alexion Pharmaceuticals » speaking at PPMA 2020

Fabrizio Zucca, Director Patient Access Dach, Sobi

Fabrizio Zucca | Director Patient Access Dach | Sobi » speaking at PPMA 2020

 

 

Contact us

To sponsor or exhibit:
Edmond Rama
+44 (0)207 092 1052

edmond.rama@terrapinn.com

To speak:
Chris Shanks
+44 (0)207 092 1151

chris.shanks@terrapinn.com